• Contact Us
Tuesday, March 2, 2021
Health Business
Advertisement
  • Home
  • News
    New TB research may lead to ‘perfect drug’

    Six counties record increase in TB cases, new report shows

    Why managing blood pressure matters during COVID-19 pandemic

    Africa’s universal health coverage agenda on course amid COVID-19 shocks

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Three ways virtual reality could transform mental health treatment

    Three ways virtual reality could transform mental health treatment

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    New TB research may lead to ‘perfect drug’

    Six counties record increase in TB cases, new report shows

    Why managing blood pressure matters during COVID-19 pandemic

    Africa’s universal health coverage agenda on course amid COVID-19 shocks

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Boehringer Ingelheim recognized for its contribution towards access to healthcare

    Three ways virtual reality could transform mental health treatment

    Three ways virtual reality could transform mental health treatment

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Public health campaign central to the promotion of COVID-19 vaccine in Africa

by Health Business
February 17, 2021
in News
0
Life-saving coronavirus drug ‘major breakthrough’
Share This:

By Julie Ngigi | juliengigi@gmail.com

The world is gearing up for the largest vaccination campaign in the history of mankind; The COVID-19 vaccination drive.

The vaccine is largely seen as a saviour from the untold suffering and disruptions that the world experienced in 2020 when the virus spread globally infecting and killing millions, overwhelming health systems, and distracting livelihoods.

High-Income Countries (HICs) including the United Kingdom, USA, Canada and Belgium have started acquiring the vaccine and inoculating their citizens against the deadly virus with fully trialled and tested COVID-19 vaccines.

Countries in the global south, however, will have to wait longer for the life-saving vaccine owing to high global demand and pressure it presents to the supply chain and other familiar barriers such as the cost of the vaccine.

WHO estimates that Africa will require around US$5.7 billion excluding other costs such as delivery, training, and community mobilization. Kenya for instance placed an order of 24 million AstraZeneca vaccines that are expected to land in the country in the first half of February 2021.

This first order was made possible through an African Union initiative that is aimed at ensuring that African nations are not left out in vaccination exercise.

Kenya is also among the 156 countries to sign an agreement with COVAX through WHO to help in the acquisition of the muchneeded vaccine.

Other African countries, donors, health agencies, and health initiatives such as COVAX are working round the clock to ensure that Low-Income Countries (LICs) are not left out in this global vaccination drive by ensuring fair and equitable access to approved COVID-19 Vaccines.

The acquisition of the life-saving vaccine however is only the battle half won, the success of the mass vaccination exercise depends on vaccine acceptability and uptake by people.

To win the battle against COVID-19, scientists are banking on boosting herd immunity that is achieved when a large section of the population is infected and recovered or when a large section of the population is vaccinated against a pathogen.

To this end, Africa has set the ambitious goal of vaccinating 200 million of her people in the next 2-3 years. According to a study conducted by Africa Centre for Disease Control and Prevention (Africa CDC) and London School of Hygiene & Tropical Medicine (LSHTM), 79 per cent of respondents said they would take the vaccine if deemed safe and effective.

This means that relentless promotion of the vaccine to create awareness, dispel myths, and promote uptake should take entre stage in preparation of the mass vaccination drive to ensure a successful rollout.

Experts need to keep in mind that promotion of the vaccine will happen against a backdrop of a global decline in vaccine acceptability compounded by COVID-19 and COVID-19 infodemic largely characterized by growing myths and conspiracy theories.

Health promotion strategies need to be designed to address these issues that could propagate COVID-19 vaccine hesitancy. In addition, the health promotion strategies need to be grounded in research; conducting in-depth Knowledge, Attitude and Perception surveys should be a priority before designing and rolling out Vaccine promotion campaigns.

Efficient and effective vaccination messages need to be delivered through the right channels; the audiences are fast evolving due to the dynamic media landscape meaning the audiences are evolving fast. Careful mapping of the audience needs to be done to ensure that everyone has been educated about the vaccine particularly those who are in rural areas.

This calls for creativity in channelling messages away from traditional and digital media. Lessons learnt from previous public health campaign will come in handy in designing COVID-19 vaccine promotion strategies, Kenya for example has had successful public health campaigns such as Polio, malaria and Guinea worm campaigns successfully.

The success of past campaign should serve as an assurance that an effective campaign to promote COVID-19 is possible.

Share This:
Previous Post

"How Covid-19 pandemic has been a blessing in disguise"

Next Post

How the coronavirus mutates and what this means for the future of COVID-19

Related Posts

New TB research may lead to ‘perfect drug’
News

Six counties record increase in TB cases, new report shows

March 2, 2021
Why managing blood pressure matters during COVID-19 pandemic
News

Africa’s universal health coverage agenda on course amid COVID-19 shocks

March 1, 2021
Boehringer Ingelheim recognized for its contribution towards access to healthcare
News

Boehringer Ingelheim recognized for its contribution towards access to healthcare

March 1, 2021
Next Post
Coronavirus new variant – genomics researcher answers key questions

How the coronavirus mutates and what this means for the future of COVID-19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Statement by WHO Director-General on World Health Day 2019

    WHO and partners launch vaccine injury compensation program for poorer countries

    0 shares
    Share 0 Tweet 0
  • Nakuru county starts construction of Sh157m Njoro Sub-County Referral Hospital

    0 shares
    Share 0 Tweet 0
  • Unitaid, partners launch COVID-19 oxygen emergency taskforce to help low-income countries

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

New TB research may lead to ‘perfect drug’

Six counties record increase in TB cases, new report shows

March 2, 2021
Why managing blood pressure matters during COVID-19 pandemic

Africa’s universal health coverage agenda on course amid COVID-19 shocks

March 1, 2021
Boehringer Ingelheim recognized for its contribution towards access to healthcare

Boehringer Ingelheim recognized for its contribution towards access to healthcare

March 1, 2021

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.